Middle East and Africa Transcatheter Pulmonary Valve Therapy Market: By Product Type, By End Users and Country Forecast 2020-2031
Middle East And Africa Transcatheter Pulmonary Valve (TPV) Therapy Market size was valued at US$ xx million in 2024 and is expected to reach US$ xx million by 2031, growing at a significant CAGR of x% from 2025-2031. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases, expansion of business by the companies in Middle east region, economic growth, and prolonged efficiency of transcatheter pulmonary valves are anticipated to propel the Middle East and Africa TPV therapy market over the forecast years. However, stringent regulations for product approval, lack of awareness in underdeveloped countries, and high cost of therapy may hamper the growth of the market.
Increase in the prevalence of congenital heart diseases is a key factor drive the growth of market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of TPV therapy market.
Geographically, Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries transcatheter pulmonary valve therapy market is growing at significant rate due to entry of companies into Middle East region, increase in healthcare expenditure, and rise in adoption of newer devices are anticipated to fuel the market. South Africa transcatheter pulmonary valve therapy market has a significant share due increase in awareness about transcatheter valves efficiency, rising healthcare expenditure, and rise in prevalence of congenital heart disease are bolster the market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
product type |
|
|
end user |
|
|
country |
|
Download Free Sample Report
2024 is the base year and 2031 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Sample
